U.S., April 29 -- ClinicalTrials.gov registry received information related to the study (NCT07553520) titled 'Dietary Cysteine and Methionine Deprivation (CMD) in Glioma Patients' on April 20.
Brief Summary: This pilot study looks at how certain diet changes affect the body in patients with recurrent brain tumors (glioma) who are planning to have standard treatment like radiation or surgery. Up to 30 patients will be randomly assigned to either a regular diet or a special diet that limits two nutrients (cysteine and methionine) for 2, 4, or 7 days before their treatment.
Patients will be monitored for side effects using blood tests and questionnaires, and patients will keep a diary to track how well they follow the diet. Blood and urine s...